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caused by this organism results in significant 
morbidity and mortality [Brenwald et al., 
2000].  Pseudomonas aeruginosa was reported to 
be the sixth most common nosocomial agent 
and second most common pathogen in ven-
tilator associated pneumonia in United States 
of American hospitals [Lawrence and Barret, 
1998]. This organism is considered one of 
the major problems in the hospital showing 
ABSTRACT 
Pseudomonas aeruginosa is an important opportunistic pathogen and one of the leading causes of 
multi-drug resistant nosocomial infections. This study was therefore carried out to determine the re-
sistance nature, and the role of efflux pump in multidrug resistance of Pseudomonas aeruginosa iso-
lated from different environmental sources using the efflux pump inhibitor, Carbonyl Cyanide 3-
Chlorophenylhydrazone (CCCP). A total of 220 environmental samples were collected and processed 
following standard techniques. Susceptibility to antibiotics was performed using disc diffusion methods 
as described by the Clinical and Laboratory Standards Institute. Activity of the efflux pump system was 
carried out using the efflux pump inhibitor, CCCP. Results obtained identified 100 (45.5%) Pseudomo-
nas aeruginosa and 72 (32.7%) other strains of Pseudomonas spp. The susceptibility testing revealed 
that all the identified strains of Pseudomonas aeruginosa that were subjected to susceptibility test 
were significantly resistant to ampicillin and cefotaxime, But the  resistance profile of isolates to tetra-
cycline, chloramphenicol, ceftriaxone, cefuroxime and perfloxacin were 93%, 72.1%, 79.1%, 58.1% 
and 51.2% respectively. However, imipenem was the most sensitive (100%), followed by cefepime 
(65%) and gentamicin (44%). Carbonyl Cyanide 3-Chlorophenylhydrazone decreased the minimum 
inhibitory concentration (MIC) of the isolates by 2 folds. Results obtained have shown the ubiquitous 
presence of multi-drug resistant P. aeruginosa from the environmental samples examined. Further-
more, it indicated the role of efflux pump in antibiotics resistance in P. aeruginosa isolates which indi-
cate that P. aeruginosa strains from environmental sources could resist antibiotics by the efflux mech-
anism.    
Keywords: Multi-Drug Resistance, Efflux pump Inhibitor; CCCP, Pseudomonas aeruginosa, Environ-
mental sources 
INTRODUCTION 
Pseudomonas aeruginosa is an aerobic, gram 
negative rod that can be found virtually eve-
rywhere: soil, plants/animals, hospital, res-
ervoir of water, sinks, toilet water and 
showers [Blais et al., 1999, Dubois et al., 
2001]. It is an opportunistic pathogen that 
initiates a variety of infections especially in 
immune-compromised patients.  Infections 
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significant degree of intrinsic and acquired 
resistance to at least one or more antibiotics 
in virtually all the major classes [Beta-
lactams, aminoglycosides,  quinolones] of 
antibiotics used in the treatment of P. aeru-
ginosa infections [ Li et al., 1994; Coats, 
1998].  
 
Gram-negative organisms, multi-drug 
pumps with specificity function act syner-
gistically with other outer membrane barrier 
to provide intrinsic and/or acquired multi-
drug resistance.  It is thus well known that 
several strains in the family Pseudomonadaceae 
show significant resistance to a wide variety 
of structurally unrelated compound such as 
antibacterial agents and organic solvents 
[Kohler et al.,1997; Kohler et  al.,1999a; 
Kohler et al.,1999b; Kieboom et al..2000] 
and they are widely distributed in nature 
showing resistant to different antibiotics 
and disinfectant, in addition to its armoury 
of putative virulence factors plus plasmid-
acquired resistance [Olayinka et al., 2009]. 
 
Efflux system which presents a vital prob-
lem to chemotherapy has been defined as 
partial or total extrusion of antibiotics from 
the targeted site of the organism [Blais et al., 
1999; Brenwald et al., 2000; Lawrence and 
Barrett, 1998]. This efflux system, no doubt 
has been broadly recognized as a major 
component of resistance to many classes of 
antibiotics. Some efflux pumps selectively 
extrude antibiotics, while other referred to 
as multi-drug resistance (MDR) pumps a 
variety of structurally diverse compound 
with differing antibacterial mode of action 
[Nikaido, 1996; Brown and Izundu, 2004].  
 
In Nigeria, reports on antibiotics resistance 
have been established and findings on ef-
flux mediated resistance in different foods 
have also been reported (Okeke et al., 
2000) . Pseudomonas aeruginosa from clinical 
specimens have been known for their multi-
drug resistant characteristics through differ-
ent mechanisms [Poirel et al., 2001].  Efflux 
pump mediated multidrug resistant Pseudomo-
nas aeruginosa of nosocomial origin have also 
been widely reported [Kohler et al., 2001]. In 
Ekiti State, the antibiotic resistance pattern 
of Pseudomonas aeruginosa isolated from clinical 
samples had been reported by Agbalajobi et 
al. [2016] while Eyo et al. [2015] in Calabar 
reported the antibiotic resistance profiles of 
clinical and environmental isolates of  P.  
aeruginosa. However, there is paucity of infor-
mation on the multidrug resistance nature of 
P. aeruginosa isolated from environmental 
sources in the studied area. Considering the 
fact that P. aeruginosa  is naturally resistant to 
many of the widely  used antibiotics making  
treatment to be often difficult, also the fact 
that environment and items in the environ-
ment are prone to contamination especially 
in Nigeria where hygienic practices is low, 
standard of living is high, and antibiotic mis-
use and abuse is rampant. The study was 
therefore aimed at detecting the resistance 
profile, and the effect of efflux pump in mul-
ti-drug resistance of Pseudomonas aeruginosa 
isolated from the commonly used/exposed 
environmental items. The information or 
findings obtained could be helpful in devis-
ing appropriate preventive/control measures 
that would be of use to the society.  
 
MATERIALS AND METHODS 
Study area 
This study was conducted at the Laboratory 
of the Department of Microbiology, Olabisi 
Onabanjo University, Ago-Iwoye, Ogun 
State, Nigeria and samples were collected 
from Ago-Iwoye and its environs. 
 
Specimen collection and transportation 
All the specimens were collected within one 
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hour of getting to the respective locations 
according to Blais et al. (1999]. The soil 
specimens were randomly collected from 
different locations in agricultural areas using 
pre sterilized auger 8.5cm in diameter from 
the top 0.20cm deep into a sterilized Mac-
Cartney bottles in compliance with Organi-
zation for Economics, Cooperation and 
Development Guideline, [2011] for soil 
sampling. Water samples (tap water) were 
aseptically collected into sterile bottles that 
contained 0.1% sodium thiosulphate 
(100mg/L) by flaming the mouth of the tap 
with a spirit lamp and allowed water to flow 
out for about 5 minutes. Sodium thiosul-
phate served to deactivate any chlorine that 
might be present in the tap water samples. 
Samples were also obtained from the sur-
face of table and laboratory sink using swab 
stick, which were then put into nutrient 
broth and fully labeled, packaged and stored 
in an ice pack bags for microbiological anal-
ysis. The maximum time from sampling 
time to culture was 12 hours. 
 
Isolation and Identification 
A minimum of 30 samples were taken from 
different locations resulting in 220 separate 
samples (Table swab = 40, Lab. Sink = 30, 
Water sample = 30, Soil sample = 30 and 
Dumpsite sample = 90). Bacteriology was 
performed according to the standard oper-
ating procedures of the laboratory [Afiukwa 
et al., 2011]. On receipt of the specimens, 
each specimen was immediately registered 
and processed according to the standard 
operating procedures of the laboratory. The 
samples were inoculated onto plates of so-
lidified cetrimide agar of known sterility 
(Himedia, India), and incubated at 370C for 
24 hours. Subcultures were carried out from 
24 hours old culture to obtain pure cultures 
that were used for subsequent characteriza-
tion tests. The plates were read for the pres-
ence of bacterial colonies. Gram staining 
technique was employed and the isolates 
were identified to species level using bio-
chemical tests [Clinical and Laboratory 
Standards Institute, 2015]. 
 
Antibacterial susceptibility testing 
Antibacterial assay was performed using agar 
disc diffusion method [Livemore, 2005; Clin-
ical and Laboratory Standards Institute, 
2015]. Mueller Hinton agar (Biotech, UK) 
was prepared according to the manufactur-
er’s instruction, autoclaved and dispensed at 
20 ml per plate in 12 × 12 cm Petri-dishes. 
The plates were incubated overnight to en-
sure sterility before use. Each labeled medi-
um plate was uniformly inoculated with 0.5 
McFarland standard of overnight broth cul-
ture of the test organisms using flooding 
method. The culture plates were dried in an 
incubator at 370C. A sterile forceps was used 
to place the different antibiotics disc on the 
prepared culture. All the plates after diffu-
sion were incubated at 370C for 24 hours. 
Antibacterial activity was determined by 
measuring the diameter of zones of inhibi-
tion (mm) surrounding the bacterial growth 
using a transparent meter rule [Colombini et 
al., 2000]. The result was expressed as re-
sistant, intermediate, and susceptible, accord-
ing to Clinical and Laboratory Standards In-
stitute (2015). The experiments were repeat-
ed in duplicates and expressed as mean val-
ues of the two experiments. 
 
Determination of the Minimum Inhibito-
ry Concentrations (MICs) and Minimum 
Bactericidal Concentration (MBCs) 
The Minimum Inhibitory Concentration 
(MIC) of the antibiotics for each isolate was 
determined by standard dilution technique. 
Approximately 106 colony-forming unit of 
bacterial suspension was inoculated into nu-
trient broth containing varying dilutions of 
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the tested antibiotics to obtain a final con-
centration ranging from 1 - 512 µg/ml me-
dium. Tubes were incubated at 37 0C for 24 
hours and the MICs were recorded as the 
lowest concentrations that completely in-
hibit the growth of the tested isolates. The 
minimum bactericidal concentration (MBC) 
was determined by pipetting, 0.1ml from 
each MIC concentrations as well as from 
the observed lower concentrations and in-
troduce into each culture of nutrient agar 
plates. The plates were incubated at 37 0C 
for 24 hours. The minimum bactericidal 
concentration (MBC) is the lowest concen-
tration at which no growth occurs on solid 
media. 
 
Screening of the Efflux pump Inhibitor 
in the resistance strains of Pseudomo-
nas aeruginosa 
The presence of efflux pump system in the 
resistant Pseudomonas aeruginosa was investi-
gated using standard recommended meth-
ods prescribed by Radostis et al.[2004];  Ar-
debili et al. [2014]. Briefly, Carbonyl Cyanide 
3-chlorophenyl hydrazone was incorporated 
to each Mueller Hinton agar plates that con-
tained the minimum inhibitory concentra-
tion of the antibiotics.  The MIC for these 
antibiotics was then measured again. The 
positive standard for the existence of efflux 
pump in the isolates was reduction of at least 
two folds or more in the MIC of the antibi-
otics after adding CCCP (Pumbwe et al., 
2006). According to Okeke et al., (2000), the 
presence of efflux pump system is based on 
the reduction of the MIC value of the tested 
antibiotics.  The MICs that further reduced 
after the incorporation of CCCP to the test-
ing medium containing the Pseudomonas spe-
cies were defined as being efflux positive. 
 
Statistical analysis 
The data obtained was subjected to statistical 
analysis using frequency distribution. The 
level of significance was set at P < 0.05. 
 
RESULTS 
 Out of the 220 environmental samples col-
lected, 100 (45.5%) Pseudomonas aeruginosa and 
72 (32.7%) other strains of Pseudomonas 
species were identified making it a total of 
172 isolates. However, 48 (21.8 %) speci-
mens showed no sign of growth when plated 
(Table 1). 
Table1:  Prevalence of Pseudomonas species from environmental specimens  
Types of specimen Number of specimen Other pseudomonas spe-
cies (%) 
Pseudomonas aeru-
ginosa   (%) 
----------Tables 40 7(17.5) 18(45) 
Laboratory sink 30 15(50) 7(23.3) 
Water 30 8(26.7) 21(70) 
Soil 30 13(43.3) 16(53.5) 
Dumpsite 90 29(32.2) 38(42.2) 
Total 220 72(32.7) 100(45.5) 
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Table 2 depicts the antibiotics susceptibility 
profiles of Pseudomonas aeruginosa   isolates 
identified in the study.  All the strains of 
Pseudomonas aeruginosa tested showed varied 
degrees of resistance except for Imipenem 
in which 100 % sensitivity was observed, 
this was followed by cefepime (65%). How-
ever, Ampicillin (100 %), and Cefotaxime, 
(100%) were the most resisted antibiotics. 
Tetracycline (93%) and Cefriazone (79.1%) 
were the next in the trend of resistance while 
gentamicin (16%) was observed to be the 
least resisted antibiotics by the tested isolates 
(Table 2). 
Table 2: Antibiotic susceptibility testing of environmental Pseudomonas  
Antibiotics Susceptible Intermediate      Resistant 
No % No % No % 
Ampicillin 0.0 0.0 0.0 0.0 43 100.0 
Cefuroxime 10.0 23.3 8.0 18.60 25 58.1 
Ceftriazone 3.0 6.98 6.0 13.95 34 79.1 
Cefotaxime 0.0 0.0 0.0 0.0 43 100.0 
Cefepime 28.0 65.1 2.0 4.70 13 30.0 
Imipenem 43.0 100.0 0.0 0.0 0 0.0 
Chloramphenicol 0.0 0.0 12.0 27.9 31 72.1 
Tetracycline 0.0 0.0 3.0 6.98 40 93.0 
Gentamicin 19.0 44.2 7.0 39.5 7 16.3 
Ofloxacin 0.0 0.0 22.0 51.2 21 48.8 
Perfloxacin 11.0 25.6 10.0 3.3 22 51.2 
Ciprofloxacin 17.0 39.5 8.0 18.6 18 41.9 
Table 3 and 4 present the result of the mini-
mum inhibitory concentration and the out-
come of the addition of 10µg/mL of CCCP 
to the observed MIC respectively. It was 
observed that the MICs of most Pseudomonas 
aeruginosa strains tested decreased in the 
presence of the efflux pump inhibitor 
(Table 4). All the P. aeruginosa isolates cul-
tured in Muller Hinton broth containing the 
CCCP 10µg/mL without the antibiotic, 
showed growth of bacteria, indicating that 
the CCCP did not have an antibacterial ef-
fect itself. A lowered MIC in the presence 
of CCCP was interpreted as efflux system 
while higher MIC or no effect of the MIC 
after the incorporation of CCCP was taken 
to be lack of efflux system. The results there-
fore emphasize that drug efflux pump sys-
tems contributed to resistance of ciprofloxa-
cin, cefepime, and  imipenem. However, 
gentamicin resistance observed in this study 
was thought not to be due to efflux pump 
system. This is because the incorporation of 
the CCCP  had  no effect on the previous 
MIC value. 
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Table 3: MICs of different antibiotics for Pseudomonas aeruginosa isolates  
              (N= 43)  
Antibiotics Break point 
(µ/ml) 
Number of isolates that had their MICs in each concentration 
1 2 4 8 16 32 64 128 256 512 >512 
Ampicillin 8 0 0 0 0 0 7 6 8 3 2 17 
Cefuroxime 16 0 0 0 0 10 8 16 2 1 5 1 
Cefriazone 8 0 0 0 3 6 7 1 3 5 18 0 
Cefotaxime 8 0 0 0 0 0 8 10 12 6 7 0 
Cefepime 8 0 0 8 8 2 10 3 0 0 0 0 
Imipenem 4 12 8 20 3 0 0 0 0 0 0 0 
Chloramphenicol 8 0 0 0 0 12 6 2 16 4 3 0 
Tetracycline 4 0 0 0 3 18 6 3 10 3 0 0 
Gentamicin 4 0 0 19 17 6 1 0 0 0 0 0 
Ofloxacin 2 0 0 22 18 1 2 0 0 0 0 0 
Perfloxacin 2 7 4 10 18 3 1 0 0 0 0 0 
Ciprofloxacin 1 17 18 12 6 0 0 0 0 0 0 0 
Table 4: Effect of adding CCCP on antibiotic resistance pattern of Pseudomonas  




cin in the presence 
of 10 µg/mL CCCP 
 
MIC of Cefepime 
in the presence of 
10 µg/mL CCCP 
 
MIC of Gentami-
cin in the presence 
of 10 µg/mL 
CCCP 
 
MIC of Imipenem in the 
presence of 10 µg/ML CCCP 
 
1 16 14 64 64 32 32 8 8 
2 16 4 64 32 16 16 4 2 
3 16 16 32 32 16 32 4 2 
4 8 8 64 64 8 8 4 4 
5 8 8 32 16 8 16 4 4 
6 4 4 16 8 4 32 4 2 
7 2 1 8 8 4 32 4 2 
8 2 2 8 8 4 32 4 2 
9 1 1 64 32 16 16 4 1 
10 1 1 4 4 16 32 4 2 
11 4 4 4 2 16 64 2 1 
12 4 2 4 2 16 32 2 1 
13 8 4 4 2 16 16 1 1 
14 8 2 4 2 16 32 1 1 
15 8 1 4 1 16 32 1 1 
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DISCUSSION 
The emergence of multiple antibiotic re-
sistance in Pseudomonas aeruginosa and the 
indiscriminate use of antibiotics contribute 
to the dissemination of resistant bacteria in 
the environment which brings about prob-
lem in therapy thereby generating serious 
public health issue. The ubiquitous presence 
of P. aeruginosa, its adaptable nature and 
their multi drug resistance characteristic 
have been documented [Lambert, 2002; 
Yetkin et al., 2007]. 
 
The relative higher occurrence of Pseudomo-
nas aeruginosa in environmental specimens 
compared to other Pseudomonas species 
could be due to the possession of additional 
genetic capacity compared with other spe-
cies [Lambert, 2002; Fair and Tor, 
2014].This corroborates with the finding of 
Jefferies et al. [2012] who reported this or-
ganism as the most common gram-negative 
bacteria causing nosocomial infections. Fair 
and Tor, [2014] who itemized some factors 
that increase P. aeruginosa  resistance thereby 
making its infection complicated and life 
threatening. 
 
 The observation of imipenem as the most 
efficacious in this study could mean that P. 
aeruginosa from the study area possess the 
oprD porin as it has been reported that loss 
of oprD porin is responsible for P. aerugino-
sa resistance to imipenem. Reason is that 
this bacterium needs the porin to cross the 
outer membrane Livermore, [2001] and 
oprD has be identified to be a specialized 
porin with a specific role in the uptake of 
positively charged amino acids such as ly-
sine. Also, loss of this porin has been re-
ported by Livermore, [2001] to increase the 
minimum inhibitory concentration from 1-2 
to 8-32mg/L and that 17%  rate of re-
sistance has been observed during treat-
ment. This finding agrees with the findings 
of Kohler et al. [1997], who reported the sen-
sitivity of P. aeruginosa to imipenem, peflox-
cin and ciprofloxacin.  
 
 The susceptibility of P. aeruginosa to 
cefepime and gentamicin besides imipenem 
could be due to the fact that these antibiotics 
are among the newest set of antibiotics in 
the market and their high cost may probably 
limit its use [Walaa et al., 2018]. This also 
translates that these antibiotics have not 
been abused in the study area, hence are still 
very active for the treatment of infection 
caused by this organism.  According to Liv-
ermore, [2001 extensive use of antibiotics to 
treat of P. aeruginosa has lead to selective 
pressure that encourages the development of 
resistance.  
 
Ampicillin and cefuroxine, followed by tetra-
cycline, ceftriazone, chloramphenicol and 
cefuroxime however, were the most resisted 
antibiotics by the isolates of P. aeruginosa and 
over 40% exhibited multi-drug resistance to 
more three or more antibiotics. This obser-
vation is parallel to that of Kohler et al., 
[1997]; who regarded over use of these anti-
biotics as a major factor for the emergence 
and dissemination of multi- antibiotics re-
sistance strains of several microbes. The fact 
that 41.9% of these isolates were multi-drug 
resistant showed that these isolates might 
have harbor resistance R- plasmids [Olayinka 
et al., 2009].  
 
  In this study efflux pump inhibitors re-
duced the MIC of Pseudomonas aeruginosa to 
some antibiotics.  It was reported that addi-
tion of CCCP at concentration of 25µg/mL 
decreased the MIC of different biocides 
from 2 to 25µg/ in Acinetobacter baumanni 
[Rajamohan et al., 2010]. The lowering of the 
MIC of the isolates in the presence of car-
116 J. Nat. Sci. Engr. & Tech. 2018, 17(1&2): 110-120 
*1G.C. AGU, 1B.T. THOMAS, 2O.O. SALAMI AND 1O.D. POPOOLA 
bonyl cyanide 3-chlorophenyl hydrazone 
clearly demonstrates that the resistance ob-
served in this study is intrinsic resistance 
that resulted from multi-drug efflux pumps 
within the bacterial chromosome and also 
as a result of the low permeability of the 
bacterial cellular envelopes [Olayinka et al., 
2009]. The result of this study disagrees 
with the works of [Ardebili et al., 2014] who 
observed that 86 % of the isolates became 
less resistant (2 to 64 folds) to ciprofloxacin 
in the presence of efflux pump inhibitors.  
Also, [Lin et al., 2009] reported that ciprof-
loxacin susceptibility of most isolates in-
creased in the presence of CCCP by 2 to 8 
folds. This efflux pump according to [Li et 
al., 2003] is not supported by the molecular 
structure of these pumps. The fact that a 
more active multi-drug efflux system was 
found against cefepime, gentamicin and 
imipenem may be due to the presence of 
multi-drug resistance pump (MDR) sub-
strates and these pump substrates are mole-
cules that are both lipophilic and cationic 
[Kohler et al., 1999c].  Although, acquired 
resistance by active efflux generally results 
from increased expression of MDR pumps, 
some MDR pumps are expressed at suffi-
cient level in wild type, while no mutants’ 
bacteria are affected by their intrinsic sus-
ceptibility [Radostis et al., 2004].  Results of 
this study have shown that the environmen-
tal sources examined habour varied degree 
of multidrug resistant efflux mediated Pseu-
domonas aeruginosa which is a big threat to the 
community and its environs.   
 
CONCLUSION 
In conclusion, the intrinsic resistance of 
Pseudomonas aeruginosa to multiple antibiotics 
in this study could be said to be as a result 
of efflux of these components from the 
bacterial cell. It can therefore be encour-
aged and be thought by health care profes-
sionals so as not to enhance the epidemic 
rate of multi-drug resistance bacteria in order 
to antagonize the trend of such isolates so as 
not to be the source of hospitalization in the 
vicinity. 
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